ALB SOLUTIONS

Lobbying for BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. · Pharmaceutical company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Connecticut · House · Senate · $40,000.00 income · posted Apr 15, 2026

Lobbying activity 1

Pharmacy

Issues related to regulatory and legislative developments regarding biosimilars and prescription digital therapeutics.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.